iGrow Venture Partners
Overview
iGrow Venture Partners is a venture capital firm that invests in early-stage (Seed to Series C) deep-technology companies across Europe, the United Kingdom, and the United States.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Plum | Jul 2024 | Series B | Lead |
| xCures | Jun 2026 | Series B | Co-investor |
| Alvion Pharmaceuticals | Apr 2026 | Strategic | Lead |
| Antogen, Inc. | Jun 2026 | Seed | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is iGrow Venture Partners based?
iGrow Venture Partners is headquartered in Greece.
When was iGrow Venture Partners founded?
iGrow Venture Partners was founded in 2024.
How many portfolio companies does iGrow Venture Partners have?
iGrow Venture Partners has 4 portfolio companies in Caplight's dataset.
What are some companies in iGrow Venture Partners's portfolio?
Portfolio companies visible on Caplight include Plum, xCures, Alvion Pharmaceuticals, Antogen, Inc..
What was iGrow Venture Partners's most recent investment shown here?
iGrow Venture Partners's most recent investment in this portfolio sample was in xCures in 2026.
What sectors does iGrow Venture Partners focus on?
iGrow Venture Partners focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, FinTech, Healthcare & Life Sciences, Enterprise Software, Consumer & Commerce.
What company stages does iGrow Venture Partners focus on?
iGrow Venture Partners typically invests at the Mid stage.
What is iGrow Venture Partners's AUM?
iGrow Venture Partners's assets under management are estimated between $54.0M and $54.0M.